Prediction of Human Serum Concentration–Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti‐Drug Antibodies
Ayaka Tajiri, Shogo Matsumoto, Nanami Furukawa, Kensuke Kagiyama, Hiroshi Ikeda, Kazumasa Fukasawa, Hiroki Takano · 2026
Read Prediction of Human Serum Concentration–Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti‐Drug Antibodies by Ayaka Tajiri, Shogo Matsumoto, Nanami Furukawa, Kensuke Kagiyama, Hiroshi Ikeda, Kazumasa Fukasawa, Hiroki Takano (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13626313.txt.
Description
Ayaka Tajiri and six colleagues, publishing in 2026, refine a cheaper way to forecast how antibody drugs behave in human blood. Developers usually scale up doses from cynomolgus monkeys, whose cost keeps rising, so this team used common marmosets, far smaller primates. Two arthritis and bowel drugs, golimumab and ustekinumab, were given four times each, and size-based scaling math, averaged with three earlier antibodies, predicted the human curves.
Ustekinumab's human profile was matched excellently, while golimumab's fade rate came out slightly off. Immune reactions against the human drugs were tiny or brief, clearing a key worry about repeat dosing. The authors settle on provisional scaling values and present marmosets as a workable stand-in for early pharmacokinetic work.
Catalog record
| CREATOR | Ayaka Tajiri, Shogo Matsumoto, Nanami Furukawa, Kensuke Kagiyama, Hiroshi Ikeda, Kazumasa Fukasawa, Hiroki Takano |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45660 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |